+Follow
Boscoloh
No personal profile
3
Follow
2
Followers
0
Topic
0
Badge
Posts
Hot
Boscoloh
2023-10-12
Share your opinion about this news…
RVL Pharmaceuticals plc 2023 Q2 - Results - Earnings Call Presentation
Boscoloh
2023-07-17
$Chijet Motor(CJET)$
Boscoloh
2023-05-17
$Exela Technologies, Inc.(XELA)$
Go to Tiger App to see more news
{"i18n":{"language":"en_US"},"userPageInfo":{"id":3576573674968319,"uuid":"3576573674968319","gmtCreate":1613479651315,"gmtModify":1633225275913,"name":"Boscoloh","pinyin":"boscoloh","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/b6672c087c34e4d64741396fa260da98","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":3,"tweetSize":6,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.11.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":229471308087296,"gmtCreate":1697065043417,"gmtModify":1697065048054,"author":{"id":"3576573674968319","authorId":"3576573674968319","name":"Boscoloh","avatar":"https://static.tigerbbs.com/b6672c087c34e4d64741396fa260da98","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Share your opinion about this news…","listText":"Share your opinion about this news…","text":"Share your opinion about this news…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/229471308087296","repostId":"2359837549","repostType":2,"repost":{"id":"2359837549","pubTimestamp":1692026826,"share":"https://www.laohu8.com/m/news/2359837549?lang=&edition=full","pubTime":"2023-08-14 23:27","market":"us","language":"en","title":"RVL Pharmaceuticals plc 2023 Q2 - Results - Earnings Call Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2359837549","media":"seekingalpha","summary":"The following slide deck was published by RVL Pharmaceuticals plc in conjunction with their 2023 Q2 earnings call.","content":"<html><body><p>The following slide deck was published by <a href=\"https://laohu8.com/S/RVLP\">RVL Pharmaceuticals plc</a> in conjunction with their 2023 Q2 earnings call.</p> </body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>RVL Pharmaceuticals plc 2023 Q2 - Results - Earnings Call Presentation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRVL Pharmaceuticals plc 2023 Q2 - Results - Earnings Call Presentation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-08-14 23:27 GMT+8 <a href=https://seekingalpha.com/article/4628207-rvl-pharmaceuticals-plc-2023-q2-results-earnings-call-presentation><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The following slide deck was published by RVL Pharmaceuticals plc in conjunction with their 2023 Q2 earnings call.</p>\n\n<a href=\"https://seekingalpha.com/article/4628207-rvl-pharmaceuticals-plc-2023-q2-results-earnings-call-presentation\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RVLP":"RVL Pharmaceuticals plc"},"source_url":"https://seekingalpha.com/article/4628207-rvl-pharmaceuticals-plc-2023-q2-results-earnings-call-presentation","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2359837549","content_text":"The following slide deck was published by RVL Pharmaceuticals plc in conjunction with their 2023 Q2 earnings call.","news_type":1},"isVote":1,"tweetType":1,"viewCount":33,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":198926474899728,"gmtCreate":1689602084311,"gmtModify":1689602086748,"author":{"id":"3576573674968319","authorId":"3576573674968319","name":"Boscoloh","avatar":"https://static.tigerbbs.com/b6672c087c34e4d64741396fa260da98","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/CJET\">$Chijet Motor(CJET)$ </a>","listText":"<a href=\"https://ttm.financial/S/CJET\">$Chijet Motor(CJET)$ </a>","text":"$Chijet Motor(CJET)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/198926474899728","isVote":1,"tweetType":1,"viewCount":52,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9970817059,"gmtCreate":1684259360971,"gmtModify":1684261143109,"author":{"id":"3576573674968319","authorId":"3576573674968319","name":"Boscoloh","avatar":"https://static.tigerbbs.com/b6672c087c34e4d64741396fa260da98","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/XELA\">$Exela Technologies, Inc.(XELA)$ </a>","listText":"<a href=\"https://ttm.financial/S/XELA\">$Exela Technologies, Inc.(XELA)$ </a>","text":"$Exela Technologies, Inc.(XELA)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9970817059","isVote":1,"tweetType":1,"viewCount":40,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":229471308087296,"gmtCreate":1697065043417,"gmtModify":1697065048054,"author":{"id":"3576573674968319","authorId":"3576573674968319","name":"Boscoloh","avatar":"https://static.tigerbbs.com/b6672c087c34e4d64741396fa260da98","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Share your opinion about this news…","listText":"Share your opinion about this news…","text":"Share your opinion about this news…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/229471308087296","repostId":"2359837549","repostType":2,"repost":{"id":"2359837549","pubTimestamp":1692026826,"share":"https://www.laohu8.com/m/news/2359837549?lang=&edition=full","pubTime":"2023-08-14 23:27","market":"us","language":"en","title":"RVL Pharmaceuticals plc 2023 Q2 - Results - Earnings Call Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2359837549","media":"seekingalpha","summary":"The following slide deck was published by RVL Pharmaceuticals plc in conjunction with their 2023 Q2 earnings call.","content":"<html><body><p>The following slide deck was published by <a href=\"https://laohu8.com/S/RVLP\">RVL Pharmaceuticals plc</a> in conjunction with their 2023 Q2 earnings call.</p> </body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>RVL Pharmaceuticals plc 2023 Q2 - Results - Earnings Call Presentation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRVL Pharmaceuticals plc 2023 Q2 - Results - Earnings Call Presentation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-08-14 23:27 GMT+8 <a href=https://seekingalpha.com/article/4628207-rvl-pharmaceuticals-plc-2023-q2-results-earnings-call-presentation><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The following slide deck was published by RVL Pharmaceuticals plc in conjunction with their 2023 Q2 earnings call.</p>\n\n<a href=\"https://seekingalpha.com/article/4628207-rvl-pharmaceuticals-plc-2023-q2-results-earnings-call-presentation\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RVLP":"RVL Pharmaceuticals plc"},"source_url":"https://seekingalpha.com/article/4628207-rvl-pharmaceuticals-plc-2023-q2-results-earnings-call-presentation","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2359837549","content_text":"The following slide deck was published by RVL Pharmaceuticals plc in conjunction with their 2023 Q2 earnings call.","news_type":1},"isVote":1,"tweetType":1,"viewCount":33,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":198926474899728,"gmtCreate":1689602084311,"gmtModify":1689602086748,"author":{"id":"3576573674968319","authorId":"3576573674968319","name":"Boscoloh","avatar":"https://static.tigerbbs.com/b6672c087c34e4d64741396fa260da98","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/CJET\">$Chijet Motor(CJET)$ </a>","listText":"<a href=\"https://ttm.financial/S/CJET\">$Chijet Motor(CJET)$ </a>","text":"$Chijet Motor(CJET)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/198926474899728","isVote":1,"tweetType":1,"viewCount":52,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9970817059,"gmtCreate":1684259360971,"gmtModify":1684261143109,"author":{"id":"3576573674968319","authorId":"3576573674968319","name":"Boscoloh","avatar":"https://static.tigerbbs.com/b6672c087c34e4d64741396fa260da98","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/XELA\">$Exela Technologies, Inc.(XELA)$ </a>","listText":"<a href=\"https://ttm.financial/S/XELA\">$Exela Technologies, Inc.(XELA)$ </a>","text":"$Exela Technologies, Inc.(XELA)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9970817059","isVote":1,"tweetType":1,"viewCount":40,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}
